Technical peptide guides, head-to-head comparisons, and buyer's-checklist writeups. Written for researchers evaluating compounds, sources, and testing documentation.
Research Clusters
Three clusters map the current novel-compound landscape — the triple agonist, the targeted-adipocyte investigational peptide, and the head-to-head comparison. All content is for laboratory research use only.
Triple Agonist & Sourcing
UBT251 is a triple-receptor agonist peptide engineered to engage the GLP-1, GIP, and glucagon receptor classes in a single backbone. The cluster covers the published structural profile, lyophilized handling notes, and what a lab should verify before sourcing: sequence identity, LC-MS and HPLC lot documentation, endotoxin results, and USA manufacture. PX1 supplies UBT251 as 10mg and 20mg research vials with lot-tracked certificates in the COA archive.
Targeted Adipocyte Apoptosis
CBL-514 is an investigational peptide studied in preclinical models for selective adipocyte-targeted apoptosis pathways. The cluster gathers the mechanism literature, formulation and reconstitution notes, and the documentation set a research team should expect with any lot: identity, purity, and sterility results from an accredited laboratory. PX1 supplies CBL-514 as a 10mg research vial, lot-tracked and independently tested.
UBT-251 vs Retatrutide
A side-by-side research comparison of UBT251 and Retatrutide: receptor-class coverage, backbone design, molecular profile, and supplied format. The comparison also maps where the two compounds differ as research materials — sourcing depth, lot documentation, and published handling data — so a lab can evaluate both strictly as research peptides.
FLGR242 research guide: the fragmented FST-344 construct without activin binding, albumin-binding design, research applications, and verified 5mg sourcing.
Read MoreKlotho research guide: what α-Klotho is, its FGF23 co-receptor role, the long-release alphaKlothoLR construct, handling, and verified Klotho research vials.
Read MoreCBL-514 research guide: Caliway's investigational compound studied for adipocyte-targeted apoptosis, mechanism literature, comparison with incretins, and verified 10mg sourcing.
Read MoreLooking to buy UBT251? Check PX1's coming-soon 10mg and 20mg listings, announced prices, lot-specific COA checklist and the triple-agonist development story.
Read MoreA laboratory-focused guide to PX1-S: GLP-1 receptor pharmacology, published trial evidence, analytical verification, handling, and research limitations.
Read MorePlain-language explainer: what PX13-R ('reta') is, how its GLP-1/GIP/glucagon triple mechanism differs from PX1-S and PX12-T, and what the trials show.
Read MoreWhy researchers pair the GHRH analog CJC-1295 (no DAC) with the selective GHRP ipamorelin: complementary mechanisms, pulsatile GH release, study design, and handling.
Read MoreIpamorelin is a selective growth hormone secretagogue pentapeptide. Mechanism, selectivity vs older GHRPs, published research, handling, and purity verification.
Read MoreWhere to buy PX13-R in the United States from the primary manufacturer — purity verification, vial sizing, cost per mg, storage on arrival and same-day US dispatch.
Read More